Tests and screening strategies for the diagnosis of hepatitis C

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Hepatitis C virus (HCV) infection requires timely diagnosis and management.
• Current diagnostic guidelines involve antibody screening followed by RNA testing.

Purpose of the Study:

• To outline optimal screening and diagnostic strategies for hepatitis C virus (HCV) infection.
• To emphasize the importance of risk factor-guided testing and early viral detection.

Main Methods:

• Review of current practices in HCV testing.
• Discussion of serological and molecular diagnostic assays for HCV.
• Consideration of HCV genotyping and liver biopsy for disease management.

Main Results:

• HCV RNA testing is essential for differentiating active from resolved infections and determining viral load.
• HCV genotyping aids in predicting treatment outcomes and duration.
• Liver biopsy provides valuable information for disease staging and treatment decisions.

Conclusions:

• A low threshold for HCV testing is recommended for individuals with identified risk factors.
• Integrated screening strategies incorporating risk assessment, viral RNA detection, genotyping, and potentially liver biopsy improve patient outcomes.